Ke Wang

Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Novel oat β-glucan nanoparticles for diabetes-associated colitis therapy.

Novel oat β-glucan nanoparticles for diabetes-associated colitis therapy.

Journal: Materials today. Bio
Published: August 12, 2025

Study on the effect of modified diosmetin for ulcerative colitis.

Study on the effect of modified diosmetin for ulcerative colitis.

Journal: Journal of materials science. Materials in medicine
Published: May 15, 2025

Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage.

Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage.

Journal: Cancer cell
Published: April 25, 2025

A dual-polysaccharide (carboxylated chitosan-carboxymethyl cellulose sodium) gastrointestinal dynamic response in situ hydrogel for optimized oral targeted inflammatory bowel disease therapy.

A dual-polysaccharide (carboxylated chitosan-carboxymethyl cellulose sodium) gastrointestinal dynamic response in situ hydrogel for optimized oral targeted inflammatory bowel disease therapy.

Journal: Carbohydrate polymers
Published: February 17, 2025

Cancer-associated SPOP mutations enlarge nuclear size and facilitate nuclear envelope rupture upon farnesyltransferase inhibitor treatment.

Cancer-associated SPOP mutations enlarge nuclear size and facilitate nuclear envelope rupture upon farnesyltransferase inhibitor treatment.

Journal: The Journal of clinical investigation
Published: November 11, 2024

Layer by layer self-assembled hyaluronic acid nanoarmor for the treatment of ulcerative colitis.

Layer by layer self-assembled hyaluronic acid nanoarmor for the treatment of ulcerative colitis.

Journal: Journal of nanobiotechnology
Published: May 27, 2024

DELFMUT: duplex sequencing-oriented depth estimation model for stable detection of low-frequency mutations.

DELFMUT: duplex sequencing-oriented depth estimation model for stable detection of low-frequency mutations.

Journal: Briefings in bioinformatics
Published: March 12, 2023

A mannitol-modified emodin nano-drug restores the intestinal barrier function and alleviates inflammation in a mouse model of DSS-induced ulcerative colitis.

A mannitol-modified emodin nano-drug restores the intestinal barrier function and alleviates inflammation in a mouse model of DSS-induced ulcerative colitis.

Journal: Chinese medicine
Published: January 16, 2023

Apigenin-Mn(II) loaded hyaluronic acid nanoparticles for ulcerative colitis therapy in mice.

Apigenin-Mn(II) loaded hyaluronic acid nanoparticles for ulcerative colitis therapy in mice.

Journal: Frontiers in chemistry
Published: June 15, 2022

Reactive Oxygen Species-Responsive Polyether Micelle Nanomaterials for Targeted Treatment of Ulcerative Colitis.

Reactive Oxygen Species-Responsive Polyether Micelle Nanomaterials for Targeted Treatment of Ulcerative Colitis.

Journal: Journal of biomedical nanotechnology
Published: February 19, 2022

Hyaluronic Acid-Melatonin Nanoparticles Improve the Dysregulated Intestinal Barrier, Microbiome and Immune Response in Mice with Dextran Sodium Sulfate-Induced Colitis.

Hyaluronic Acid-Melatonin Nanoparticles Improve the Dysregulated Intestinal Barrier, Microbiome and Immune Response in Mice with Dextran Sodium Sulfate-Induced Colitis.

Journal: Journal of biomedical nanotechnology
Published: February 19, 2022

Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism.

Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism.

Journal: Pharmacological research
Published: May 22, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026